USE OF INSULIN GLARGINE TO REDUCE OR PREVENT CARDIOVASCULAR MORBIDITY AND MORTALITY IN PRE-DIABETES PATIENTS

• 收藏
• 分享

专利权人:

Aventisub LLC

发明人:

Rosskamp Ralf,Rosskamp Ralf,Gerstein Hertzel,Gerstein Hertzel

申请号：

SI200432361

公开号：

SI2596800T1

申请日:

2004.01.14

申请国别(地区):

SI

年份:

2017

代理人:

摘要：

This invention relates to a method of reducing cardiovascular morbidity and mortality in a prediabetic or Type 2 Diabetes patient population. The method comprises administering an effective dosage of a long acting insulin, preferably insulin glargine, to a prediabetic or Type 2 Diabetes patient.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/